Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.

Kobayashi M, Kato T, Washiyama K, Ihara M, Mizutani A, Nishi K, Flores LG 2nd, Nishii R, Kawai K.

PLoS One. 2019 Mar 22;14(3):e0213397. doi: 10.1371/journal.pone.0213397. eCollection 2019.

2.

Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging.

Effendi N, Mishiro K, Takarada T, Yamada D, Nishii R, Shiba K, Kinuya S, Odani A, Ogawa K.

Bioorg Med Chem. 2019 Jan 15;27(2):383-393. doi: 10.1016/j.bmc.2018.12.016. Epub 2018 Dec 11.

PMID:
30563725
3.

Statistical and Machine Learning Approaches to Predict Gene Regulatory Networks From Transcriptome Datasets.

Mochida K, Koda S, Inoue K, Nishii R.

Front Plant Sci. 2018 Nov 29;9:1770. doi: 10.3389/fpls.2018.01770. eCollection 2018. Review.

4.

Computer vision-based phenotyping for improvement of plant productivity: a machine learning perspective.

Mochida K, Koda S, Inoue K, Hirayama T, Tanaka S, Nishii R, Melgani F.

Gigascience. 2019 Jan 1;8(1). doi: 10.1093/gigascience/giy153. Review.

5.

Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer.

Kobayashi M, Tsujiuchi T, Okui Y, Mizutani A, Nishi K, Nakanishi T, Nishii R, Fukuchi K, Tamai I, Kawai K.

Pharm Res. 2018 Nov 29;36(1):18. doi: 10.1007/s11095-018-2548-5.

PMID:
30498970
6.

European research trends in nuclear medicine.

Inubushi M, Tatsumi M, Yamamoto Y, Kato K, Tsujikawa T, Nishii R.

Ann Nucl Med. 2018 Nov;32(9):579-582. doi: 10.1007/s12149-018-1303-7. Epub 2018 Sep 21. Review.

7.

Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging.

Nishii R, Higashi T, Kagawa S, Arimoto M, Kishibe Y, Takahashi M, Yamada S, Saiki M, Arakawa Y, Yamauchi H, Okuyama C, Hojo M, Munemitsu T, Sawada M, Kobayashi M, Kawai K, Nagamachi S, Hirai T, Miyamoto S.

Contrast Media Mol Imaging. 2018 Jun 20;2018:1292746. doi: 10.1155/2018/1292746. eCollection 2018.

8.

Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms.

Tsujimoto S, Osumi T, Uchiyama M, Shirai R, Moriyama T, Nishii R, Yamada Y, Kudo K, Sekiguchi M, Arakawa Y, Yoshida M, Uchiyama T, Terui K, Ito S, Koh K, Takita J, Ito E, Tomizawa D, Manabe A, Kiyokawa N, Yang JJ, Kato M.

Leukemia. 2018 Dec;32(12):2710-2714. doi: 10.1038/s41375-018-0190-1. Epub 2018 Jul 2. No abstract available.

9.

123I-iomazenil whole-body imaging to detect hepatic carboxylesterase drug-metabolizing enzyme activity.

Mizutani A, Kobayashi M, Fujita KI, Takahashi K, Hokama T, Takasu H, Nishi K, Nishii R, Shikano N, Fukuchi K, Kawai K.

Nucl Med Commun. 2018 Sep;39(9):825-833. doi: 10.1097/MNM.0000000000000875.

PMID:
29877992
10.

Do TSH, FT3, and FT4 Impact BAT Visualization of Clinical FDG-PET/CT Images?

Nishii R, Nagamachi S, Mizutani Y, Terada T, Kiyohara S, Wakamatsu H, Fujita S, Higashi T, Yoshinaga K, Saga T, Hirai T.

Contrast Media Mol Imaging. 2018 Feb 13;2018:4898365. doi: 10.1155/2018/4898365. eCollection 2018.

11.

Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy.

Nishii R, Moriyama T, Janke LJ, Yang W, Suiter CC, Lin TN, Li L, Kihira K, Toyoda H, Hofmann U, Schwab M, Takagi M, Morio T, Manabe A, Kham S, Jiang N, Rabin KR, Kato M, Koh K, Yeoh AE, Hori H, Yang JJ.

Blood. 2018 May 31;131(22):2466-2474. doi: 10.1182/blood-2017-11-815506. Epub 2018 Mar 23.

12.

Combination of common and novel rare NUDT15 variants improves predictive sensitivity of thiopurine-induced leukopenia in children with acute lymphoblastic leukemia.

Zhu Y, Yin D, Su Y, Xia X, Moriyama T, Nishii R, Liao F, Zhang S, Guo X, Hou Q, Ai Y, Zhou X, Sun S, Zhang D, Zhang Y, Lin C, Deng Y, Lu X, Wang Y, Ma Z, Wang H, Liu B, Yang L, Zhang W, Yang JJ, Shu Y, Gao J, Xu H.

Haematologica. 2018 Jul;103(7):e293-e295. doi: 10.3324/haematol.2018.187658. Epub 2018 Mar 8. No abstract available.

13.

PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Makino A, Miyazaki A, Tomoike A, Kimura H, Arimitsu K, Hirata M, Ohmomo Y, Nishii R, Okazawa H, Kiyono Y, Ono M, Saji H.

Bioorg Med Chem. 2018 May 1;26(8):1609-1613. doi: 10.1016/j.bmc.2018.02.007. Epub 2018 Feb 8.

PMID:
29478801
14.

18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging.

Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.

Ann Nucl Med. 2018 May;32(4):256-263. doi: 10.1007/s12149-018-1240-5. Epub 2018 Feb 16.

PMID:
29453681
15.

Development of radioiodine labeled acetaminophen for specific, high-contrast imaging of malignant melanoma.

Zhu WJ, Kobayashi M, Yamada K, Nishi K, Takahashi K, Mizutani A, Nishii R, Flores LG 2nd, Shikano N, Kunishima M, Kawai K.

Nucl Med Biol. 2018 Apr;59:16-21. doi: 10.1016/j.nucmedbio.2017.12.008. Epub 2018 Jan 3.

PMID:
29413752
16.

18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.

Higashi T, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.

Ann Nucl Med. 2018 Apr;32(3):206-216. doi: 10.1007/s12149-018-1236-1. Epub 2018 Jan 31.

17.

Correction to: Radiopharmaceutical tracers for cardiac imaging.

Manabe O, Kikuchi T, Scholte AJHA, El Mahdiui M, Nishii R, Zhang MR, Suzuki E, Yoshinaga K.

J Nucl Cardiol. 2018 Aug;25(4):1237-1241. doi: 10.1007/s12350-018-1184-0.

PMID:
29368086
18.

Diurnal Transcriptome and Gene Network Represented through Sparse Modeling in Brachypodium distachyon.

Koda S, Onda Y, Matsui H, Takahagi K, Yamaguchi-Uehara Y, Shimizu M, Inoue K, Yoshida T, Sakurai T, Honda H, Eguchi S, Nishii R, Mochida K.

Front Plant Sci. 2017 Nov 28;8:2055. doi: 10.3389/fpls.2017.02055. eCollection 2017.

19.

Radiopharmaceutical tracers for cardiac imaging.

Manabe O, Kikuchi T, Scholte AJHA, El Mahdiui M, Nishii R, Zhang MR, Suzuki E, Yoshinaga K.

J Nucl Cardiol. 2018 Aug;25(4):1204-1236. doi: 10.1007/s12350-017-1131-5. Epub 2017 Dec 1. Erratum in: J Nucl Cardiol. 2018 Jan 24;:.

20.

Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.

Takagi M, Yoshida M, Nemoto Y, Tamaichi H, Tsuchida R, Seki M, Uryu K, Nishii R, Miyamoto S, Saito M, Hanada R, Kaneko H, Miyano S, Kataoka K, Yoshida K, Ohira M, Hayashi Y, Nakagawara A, Ogawa S, Mizutani S, Takita J.

J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx062.

PMID:
29059438
21.

In vitro uptake and metabolism of [14C]acetate in rabbit atherosclerotic arteries: biological basis for atherosclerosis imaging with [11C]acetate.

Yamasaki K, Yamashita A, Zhao Y, Shimizu Y, Nishii R, Kawai K, Tamaki N, Zhao S, Asada Y, Kuge Y.

Nucl Med Biol. 2018 Jan;56:21-25. doi: 10.1016/j.nucmedbio.2017.08.003. Epub 2017 Aug 24.

22.

Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry.

Moriyama T, Yang YL, Nishii R, Ariffin H, Liu C, Lin TN, Yang W, Lin DT, Yu CH, Kham S, Pui CH, Evans WE, Jeha S, Relling MV, Yeoh AE, Yang JJ.

Blood. 2017 Sep 7;130(10):1209-1212. doi: 10.1182/blood-2017-05-782383. Epub 2017 Jun 28.

23.

Usefulness of 11C-methionine-PET for predicting the efficacy of carbon ion radiation therapy for head and neck mucosal malignant melanoma.

Hasebe M, Yoshikawa K, Nishii R, Kawaguchi K, Kamada T, Hamada Y.

Int J Oral Maxillofac Surg. 2017 Oct;46(10):1220-1228. doi: 10.1016/j.ijom.2017.04.019. Epub 2017 May 20.

PMID:
28535963
24.

The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.

Moriyama T, Nishii R, Lin TN, Kihira K, Toyoda H, Jacob N, Kato M, Koh K, Inaba H, Manabe A, Schmiegelow K, Yang JJ, Hori H.

Pharmacogenet Genomics. 2017 Jun;27(6):236-239. doi: 10.1097/FPC.0000000000000282.

25.

18F-Labeled Pyrido[3,4-d]pyrimidine as an Effective Probe for Imaging of L858R Mutant Epidermal Growth Factor Receptor.

Kimura H, Okuda H, Ishiguro M, Arimitsu K, Makino A, Nishii R, Miyazaki A, Yagi Y, Watanabe H, Kawasaki I, Ono M, Saji H.

ACS Med Chem Lett. 2017 Mar 20;8(4):418-422. doi: 10.1021/acsmedchemlett.6b00520. eCollection 2017 Apr 13.

26.

Usefulness of 2D fusion of postmortem CT and antemortem chest radiography studies for human identification.

Shinkawa N, Hirai T, Nishii R, Yukawa N.

Jpn J Radiol. 2017 Jun;35(6):303-309. doi: 10.1007/s11604-017-0632-0. Epub 2017 Mar 14.

PMID:
28293771
27.

Relationship between [14C]MeAIB uptake and amino acid transporter family gene expression levels or proliferative activity in a pilot study in human carcinoma cells: Comparison with [3H]methionine uptake.

Kagawa S, Nishii R, Higashi T, Yamauchi H, Ogawa E, Okudaira H, Kobayashi M, Yoshimoto M, Shikano N, Kawai K.

Nucl Med Biol. 2017 Jun;49:8-15. doi: 10.1016/j.nucmedbio.2017.01.008. Epub 2017 Jan 26.

PMID:
28284101
28.

Differences in accumulation and the transport mechanism of l- and d-methionine in high- and low-grade human glioma cells.

Kobayashi M, Mizutani A, Nishi K, Nakajima S, Shikano N, Nishii R, Fukuchi K, Kawai K.

Nucl Med Biol. 2017 Jan;44:78-82. doi: 10.1016/j.nucmedbio.2016.09.003. Epub 2016 Sep 14.

PMID:
27835793
29.

(11)C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with (18)F-fluorodeoxyglucose PET.

Arimoto MK, Higashi T, Nishii R, Kagawa S, Takahashi M, Kishibe Y, Yamauchi H, Ishitoya S, Oonishi H, Nakamoto Y, Togashi K.

Ann Nucl Med. 2016 Oct;30(8):553-62. doi: 10.1007/s12149-016-1098-3. Epub 2016 Jun 21.

PMID:
27329084
30.

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.

Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann FA, Zhao X, Lin TN, Hoshitsuki K, Nersting J, Kihira K, Hofmann U, Komada Y, Kato M, McCorkle R, Li L, Koh K, Najera CR, Kham SK, Isobe T, Chen Z, Chiew EK, Bhojwani D, Jeffries C, Lu Y, Schwab M, Inaba H, Pui CH, Relling MV, Manabe A, Hori H, Schmiegelow K, Yeoh AE, Evans WE, Yang JJ.

Nat Genet. 2016 Apr;48(4):367-73. doi: 10.1038/ng.3508. Epub 2016 Feb 15.

31.

Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.

Moriyama T, Metzger ML, Wu G, Nishii R, Qian M, Devidas M, Yang W, Cheng C, Cao X, Quinn E, Raimondi S, Gastier-Foster JM, Raetz E, Larsen E, Martin PL, Bowman WP, Winick N, Komada Y, Wang S, Edmonson M, Xu H, Mardis E, Fulton R, Pui CH, Mullighan C, Evans WE, Zhang J, Hunger SP, Relling MV, Nichols KE, Loh ML, Yang JJ.

Lancet Oncol. 2015 Dec;16(16):1659-66. doi: 10.1016/S1470-2045(15)00369-1. Epub 2015 Oct 28.

32.

Increase in [18F]-Fluoroacetate Uptake in Patients With Chronic Hemodynamic Cerebral Ischemia.

Yamauchi H, Kagawa S, Kishibe Y, Takahashi M, Nishii R, Mizuma H, Takahashi K, Onoe H, Higashi T.

Stroke. 2015 Sep;46(9):2669-72. doi: 10.1161/STROKEAHA.115.010080. Epub 2015 Jul 30.

PMID:
26304865
33.

CT evaluation of acupuncture needles inserted into sacral foramina.

Katayama Y, Kamibeppu T, Nishii R, Mukai S, Wakeda H, Kamoto T.

Acupunct Med. 2016 Feb;34(1):20-6. doi: 10.1136/acupmed-2015-010775. Epub 2015 Aug 5.

PMID:
26245585
34.

Development of radioiodine-labeled 4-hydroxyphenylcysteamine for specific diagnosis of malignant melanoma.

Kobayashi M, Nishii R, Shikano N, Flores LG 2nd, Mizutani A, Ogai K, Sugama J, Nagamachi S, Kawai K.

Nucl Med Biol. 2015 Jun;42(6):536-40. doi: 10.1016/j.nucmedbio.2015.02.004. Epub 2015 Feb 20.

PMID:
25744361
35.

In vivo radioactive metabolite analysis for individualized medicine: a basic study of a new method of CYP activity assay using (123)I-IMP.

Nishi K, Mizutani A, Shikano N, Fujita K, Kobayashi M, Ono M, Nishii R, Sasaki Y, Kinuya S, Kawai K.

Nucl Med Biol. 2015 Feb;42(2):171-6. doi: 10.1016/j.nucmedbio.2014.08.015. Epub 2014 Sep 6.

PMID:
25441254
36.

Assessment of the efficacy of early phase parameters by (123)I-MIBG dynamic imaging for distinguishing Lewy body-related diseases from Parkinson's syndrome.

Shiiba T, Nishii R, Sasaki M, Kihara Y, Tsuruta K, Maeda M, Morishita J.

Ann Nucl Med. 2015 Feb;29(2):149-56. doi: 10.1007/s12149-014-0923-9. Epub 2014 Nov 1.

PMID:
25366472
37.

Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.

Kobayashi M, Nakanishi T, Nishi K, Higaki Y, Okudaira H, Ono M, Tsujiuchi T, Mizutani A, Nishii R, Tamai I, Arano Y, Kawai K.

Nucl Med Biol. 2014 Apr;41(4):338-42. doi: 10.1016/j.nucmedbio.2014.01.004. Epub 2014 Jan 13.

PMID:
24607436
38.

Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.

Takemoto K, Hatano E, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Yamauchi H, Matsumura K, Zaima M, Toriguchi K, Tanabe K, Kitamura K, Seo S, Taura K, Endo K, Uemoto S, Higashi T.

Ann Nucl Med. 2014 May;28(4):371-80. doi: 10.1007/s12149-014-0823-z. Epub 2014 Mar 6.

PMID:
24599824
39.

Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expression.

Yoshimoto M, Hirata M, Kanai Y, Naka S, Nishii R, Kagawa S, Kawai K, Ohmomo Y.

Biol Pharm Bull. 2014;37(3):355-60.

40.

BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors.

Tsuchida R, Osawa T, Wang F, Nishii R, Das B, Tsuchida S, Muramatsu M, Takahashi T, Inoue T, Wada Y, Minami T, Yuasa Y, Shibuya M.

Oncogene. 2014 Jul 17;33(29):3803-11. doi: 10.1038/onc.2013.358. Epub 2013 Sep 9.

PMID:
24013228
41.

Diagnostic usefulness of an amino acid tracer, α-[N-methyl-(11)C]-methylaminoisobutyric acid ( (11)C-MeAIB), in the PET diagnosis of chest malignancies.

Nishii R, Higashi T, Kagawa S, Kishibe Y, Takahashi M, Yamauchi H, Motoyama H, Kawakami K, Nakaoku T, Nohara J, Okamura M, Watanabe T, Nakatani K, Nagamachi S, Tamura S, Kawai K, Kobayashi M.

Ann Nucl Med. 2013 Nov;27(9):808-21. doi: 10.1007/s12149-013-0750-4. Epub 2013 Jul 4.

42.

Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.

Yoshii Y, Furukawa T, Oyama N, Hasegawa Y, Kiyono Y, Nishii R, Waki A, Tsuji AB, Sogawa C, Wakizaka H, Fukumura T, Yoshii H, Fujibayashi Y, Lewis JS, Saga T.

PLoS One. 2013 May 31;8(5):e64570. doi: 10.1371/journal.pone.0064570. Print 2013.

43.

The usefulness of (18)F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with (18)F-FDG PET/CT.

Nagamachi S, Nishii R, Wakamatsu H, Mizutani Y, Kiyohara S, Fujita S, Futami S, Sakae T, Furukoji E, Tamura S, Arita H, Chijiiwa K, Kawai K.

Ann Nucl Med. 2013 Jul;27(6):554-63. doi: 10.1007/s12149-013-0719-3. Epub 2013 Apr 12.

PMID:
23580090
44.

Short communication: effects of serum obtained from dairy cows with low or high body condition score on in vitro embryo development.

Oba M, Miyashita S, Nishii R, Koiwa M, Koyama H, Ambrose DJ, Dochi O.

J Dairy Sci. 2013 Mar;96(3):1668-71. doi: 10.3168/jds.2012-5886. Epub 2013 Jan 16.

45.

Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method.

Nishi K, Kobayashi M, Nishii R, Shikano N, Takamura N, Kuga N, Yamasaki K, Nagamachi S, Tamura S, Otagiri M, Kawai K.

Nucl Med Biol. 2013 Apr;40(3):366-70. doi: 10.1016/j.nucmedbio.2012.12.002. Epub 2013 Jan 9.

PMID:
23312701
46.

Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹⁸F-FAHA.

Yeh HH, Tian M, Hinz R, Young D, Shavrin A, Mukhapadhyay U, Flores LG, Balatoni J, Soghomonyan S, Jeong HJ, Pal A, Uthamanthil R, Jackson JN, Nishii R, Mizuma H, Onoe H, Kagawa S, Higashi T, Fukumitsu N, Alauddin M, Tong W, Herholz K, Gelovani JG.

Neuroimage. 2013 Jan 1;64:630-9. doi: 10.1016/j.neuroimage.2012.09.019. Epub 2012 Sep 17.

47.

Transport mechanism of (11)C-labeled L- and D-methionine in human-derived tumor cells.

Kobayashi M, Hashimoto F, Ohe K, Nadamura T, Nishi K, Shikano N, Nishii R, Higashi T, Okazawa H, Kawai K.

Nucl Med Biol. 2012 Nov;39(8):1213-8. doi: 10.1016/j.nucmedbio.2012.06.006. Epub 2012 Jul 12.

PMID:
22795787
48.

Is misery perfusion still a predictor of stroke in symptomatic major cerebral artery disease?

Yamauchi H, Higashi T, Kagawa S, Nishii R, Kudo T, Sugimoto K, Okazawa H, Fukuyama H.

Brain. 2012 Aug;135(Pt 8):2515-26. doi: 10.1093/brain/aws131. Epub 2012 May 24.

PMID:
22637544
49.

Passive toothbrushing-induced seizures: report of a severely disabled girl.

Kumada T, Nishii R, Higashi T, Miyajima T, Saito K, Hiejima I, Nozaki F, Hayashi A, Fujii T.

Brain Dev. 2013 Jan;35(1):91-4. doi: 10.1016/j.braindev.2012.03.013. Epub 2012 Apr 18.

PMID:
22521108
50.

[Ketogenic diet may control seizures by increasing the binding potential of the benzodiazepine receptor: a speculation from the [11C] flumazenil-PET study].

Kumada T, Nishii R, Higashi T, Miyajima T, Oda N, Shimomura H, Saito K, Fujii T.

No To Hattatsu. 2012 Jan;44(1):50-4. Japanese.

PMID:
22352031

Supplemental Content

Loading ...
Support Center